BioCentury
ARTICLE | Financial News

Arch Therapeutics proposes debt financing

October 14, 2013 7:00 AM UTC

Arch Therapeutics Inc. (OTCQB: ARTH), Wellesley, Mass. Business: Hematology Date announced: 10/7/13 Type: Debt financing To be raised: $1 million Investors: Massachusetts Life Sciences Center Note: Th...